VRS
VIVO

Virginia Retirement Systems’s Meridian Bioscience Inc VIVO Stock Holding History

Virginia Retirement Systems’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$514K Sell
19,800
-6,000
-23% -$143K ﹤0.01% 843
2021
Q4 		$526 Sell
25,800
-1,200
-4% -$23K ﹤0.01% 840
2021
Q3 		$519K Sell
27,000
-4,400
-14% -$87.7K 0.01% 786
2021
Q2 		$696K Sell
31,400
-5,800
-16% -$123K 0.01% 756
2021
Q1 		$977K Sell
37,200
-1,300
-3% -$30.9K 0.01% 671
2020
Q4 		$720K Buy
38,500
+21,900
+132% +$409K 0.01% 714
2020
Q3 		$282K Buy
+16,600
New +$323K ﹤0.01% 947
2019
Q2 		– Sell
-77,100
Closed -$1.36M – 1194
2019
Q1 		$1.36M Buy
77,100
+5,200
+7% +$86.5K 0.02% 556
2018
Q4 		$1.25M Sell
71,900
-20,400
-22% -$348K 0.02% 547
2018
Q3 		$1.38M Buy
92,300
+2,300
+3% +$35.7K 0.02% 586
2018
Q2 		$1.43M Buy
90,000
+100
+0.1% +$1.49K 0.02% 552
2018
Q1 		$1.28M Buy
89,900
+31,500
+54% +$466K 0.02% 575
2017
Q4 		$818K Sell
58,400
-4,300
-7% -$62.9K 0.01% 706
2017
Q3 		$897K Sell
62,700
-14,300
-19% -$204K 0.01% 693
2017
Q2 		$1.21M Sell
77,000
-100
-0.1% -$1.44K 0.02% 609
2017
Q1 		$1.06M Buy
77,100
+2,300
+3% +$32.2K 0.01% 641
2016
Q4 		$1.32M Buy
74,800
+9,200
+14% +$162K 0.02% 522
2016
Q3 		$1.26M Buy
65,600
+4,700
+8% +$92K 0.02% 508
2016
Q2 		$1.19M Buy
+60,900
New +$1.19M 0.02% 515
2015
Q4 		$1.37M Hold
66,600
– – 0.02% 455
2015
Q3 		$1.14M Sell
66,600
-600
-0.9% -$11K 0.02% 496
2015
Q2 		$1.25M Hold
67,200
– – 0.02% 489
2015
Q1 		$1.28M Hold
67,200
– – 0.02% 479
2014
Q4 		$1.11M Buy
67,200
+54,600
+433% +$937K 0.02% 486
2014
Q3 		$223K Hold
12,600
– – ﹤0.01% 892
2014
Q2 		$260K Sell
12,600
-100
-0.8% -$2.06K ﹤0.01% 864
2014
Q1 		$277K Hold
12,700
– – 0.01% 824
2013
Q4 		$337K Sell
12,700
-3,500
-22% -$86K 0.01% 721
2013
Q3 		$383K Buy
+16,200
New +$378K 0.01% 666

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virginia Retirement Systems's VIVO Position: Q1 2022 in Review

Virginia Retirement Systems reduced its Meridian Bioscience Inc (VIVO) stake by 23% in Q1 2022, selling an estimated $143K and leaving 19,800 shares worth $514K. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Virginia Retirement Systems first reported a position in VIVO in Q3 2013 and has held it in 29 quarters since. The position peaked at $1.43M in Q2 2018. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

  • Virginia Retirement Systems held 19,800 shares of Meridian Bioscience Inc worth $514K as of Q1 2022.
  • Virginia Retirement Systems sold 6,000 Meridian Bioscience Inc shares in Q1 2022, an estimated $143K.
  • Meridian Bioscience Inc made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q1 2022, its #843 holding.
  • Virginia Retirement Systems first reported a position in Meridian Bioscience Inc in Q3 2013 and has held it in 29 quarters since.
  • Virginia Retirement Systems's Meridian Bioscience Inc position peaked at $1.43M in Q2 2018.
  • 210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.